Dr. Bystrom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 Bramhall St
Portland, ME 04102Phone+1 207-662-0111
Education & Training
- Maine Medical CenterResidency, Internal Medicine, 2018 - 2020
- The Flinders University of South Australia School of MedicineClass of 2016
Certifications & Licensure
- MA State Medical License 2023 - 2026
- ME State Medical License 2020 - 2025
- NC State Medical License 2025 - 2025
- DC State Medical License 2021 - 2024
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Acute myeloid leukemia (AML) with chromosome 3 inversion: biology, management, and clinical outcome.Abdulrahman Alhajahjeh, Jan Philipp Bewersdorf, Rebecca P Bystrom, Amer M Zeidan, Shai Shimony
Leukemia & Lymphoma. 2024-11-01 - 1 citationsIntensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML.Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton
Blood Advances. 2024-09-24 - 2 citationsCombination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A...Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton
American Journal of Hematology. 2024-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: